View source for Effectiveness along with basic safety associated with apatinib monotherapy in metastatic kidney mobile or portable carcinoma mRCC patients The singlearm observational research
From EECH Central
You do not have permission to edit this page, for the following reasons:
You can view and copy the source of this page.